Bypassing IgE and targeting T cells for specific immunotherapy of allergy (Q34198873)

31 July 2017

1 reference

title

Bypassing IgE and targeting T cells for specific immunotherapy of allergy (English)

1 reference

31 July 2017

1 reference

Akdis CA

1

1 reference

PubMed ID

11274910

31 July 2017

Blaser K

series ordinal

2

1 reference

31 July 2017

1 April 2001

1 reference

31 July 2017

1 reference

31 July 2017

22

1 reference

31 July 2017

4

1 reference

31 July 2017

175-178

1 reference

A molecular basis for T cell suppression by IL-10: CD28-associated IL-10 receptor inhibits CD28 tyrosine phosphorylation and phosphatidylinositol 3-kinase binding

31 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901862-2

7 January 2021

Epitope-specific T cell tolerance to phospholipase A2 in bee venom immunotherapy and recovery by IL-2 and IL-15 in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901862-2

7 January 2021

Interleukin 4 production by CD4+ T cells from allergic individuals is modulated by antigen concentration and antigen-presenting cell type

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901862-2

7 January 2021

Differential regulation of human T cell cytokine patterns and IgE and IgG4 responses by conformational antigen variants.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901862-2

7 January 2021

Low-affinity IgE receptor (CD23) function on mouse B cells: role in IgE-dependent antigen focusing

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901862-2

7 January 2021

Effect of transmembrane and cytoplasmic domains of IgE on the IgE response.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901862-2

7 January 2021

Central role of immunoglobulin (Ig) E in the induction of lung eosinophil infiltration and T helper 2 cell cytokine production: inhibition by a non-anaphylactogenic anti-IgE antibody

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901862-2

7 January 2021

Successful immunotherapy with T-cell epitope peptides of bee venom phospholipase A2 induces specific T-cell anergy in patients allergic to bee venom.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901862-2

7 January 2021

Effects of peptide therapy on ex vivo T-cell responses

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901862-2

7 January 2021

Studies on allergoids from naturally occurring allergens III. Preparation of ragweed pollen allergoids by aldehyde modification in two steps

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901862-2

7 January 2021

Modulation of IgE reactivity of allergens by site-directed mutagenesis: potential use of hypoallergenic variants for immunotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901862-2

7 January 2021

Contribution of disulphide bonds to antigenicity of Lep d 2, the major allergen of the dust mite Lepidoglyphus destructor.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901862-2

7 January 2021

Conversion of the major birch pollen allergen, Bet v 1, into two nonanaphylactic T cell epitope-containing fragments: candidates for a novel form of specific immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901862-2

7 January 2021

Genetic engineering of recombinant hypoallergenic oligomers of the major birch pollen allergen, Bet v 1: candidates for specific immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901862-2

7 January 2021

10.1016/S1471-4906(01)01862-2

Identifiers

DOI

1 reference

31 July 2017

1 reference

PubMed ID

11274910